Boston Scientific's new CEO takes the reins

November 1, 2012 by MassDevice staff

Michael Mahoney can finally remove the "incoming" from his title as he officially takes over the corner office at medical device company Boston Scientific.

Michael Mahoney

Boston Scientific (NYSE:BSX) officially handed the corner office over to Michael Mahoney today, marking the end of a year-long "transition period" for the new CEO.

The day came without fanfare for the medical device company, with a veritable media freeze on the new head man as he embarks on what is likely to be a busy 1st day at the helm.

Mahoney, 47, has spent just over a year at Boston Scientific as president, after being recruited from rival device maker Johnson & Johnson's (NYSE:JNJ) diagnostics and devices group.

Sign up to get our free newsletters delivered right to your inbox.

Late last year Boston Scientific announced Mahoney as the successor to former CEO J. Raymond Elliott, who manned the corner office for 2 years before announcing his retirement in May 2011. Elliott officially retired in October 2011, the day Mahoney joined the company.

"Really, the opportunity was too good to pass up," Mahoney told about the decision to accept the job at Boston Scientific.